-
Dahua's AI achieved two breakthrough key indicators to achieve industry leadership
Time of Update: 2022-01-01
developed a weakly supervised semantic segmentation technology for pathological slices in the medical field based on a self-developed training framework, and won the first place in the WSSS4LUAD competition; developed instance segmentation technology , Won the first place in the MSCOCO competition; key indicators surpass first-class AI companies and top academic research institutions, demonstrating Dahua's deep technical strength and innovative ability in the field of target segmentation .
-
DIAN-TU selected LECANEMAB as the basic anti-amyloid protein in the clinical trial of treating dominant Alzheimer's disease with TAU as the target to evaluate the effect of exploratory treatment
Time of Update: 2021-12-31
As more and more clinical research evidence shows that targeting amyloid can reduce Alzheimer's disease (AD) biomarkers, the head of Tau NexGen clinical trials chose Eisai’s exploratory anti-amyloid β ( Aβ) fibrillary antibody lecanemab as a basic anti-amyloid drug .
-
Hengrui Medicine's Class 1 innovative drug Hytrapapax is included in the new 2021 National Medical Insurance Catalogue
Time of Update: 2021-12-31
Indications included in medical insurance reimbursement include adult patients with chronic primary immune thrombocytopenia (ITP) who have not responded well to treatments such as glucocorticoids and immunoglobulins, as well as severe aplastic anemia that does not respond well to immunosuppressive therapy (SAA) Treatment of adult patients .
-
Experts explore the use of new technologies to create a new model for early screening and early diagnosis of breast cancer
Time of Update: 2021-12-31
The reporter learned on the 6th that through automatic breast full volume imaging (ABVS) combined with contrast-enhanced ultrasound examination, Shanghai experts are trying to create a new model for early screening and early diagnosis of breast cancer to improve the quality of life and survival rate of patients .
-
Tengsheng Biopharmaceuticals announced to be included in the Southbound Stock Connect list
Time of Update: 2021-12-31
prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.
62em; font-family:"Arial"; color:black; margin:0in; } Beijing, China and the United States Durham, North Carolina December 6, 2021 / PRNewswire / - Teng Sheng Bo Pharmaceutical Biotechnology Co.
com Summer Li (China) +86-135-2191-1607 Ben Shannon (United States) +1-919-360-3039Investor inquiries: ir@briibio.
-
Everyone’s pension insurance: gather a little bit of strength and walk with the public welfare
Time of Update: 2021-12-31
prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.
In 2022, Volunteer Pension Insurance Volunteers will continue to devote themselves to public welfare undertakings and actively fulfill their social responsibilities, so that they will be more grounded and more humane .
-
The benchmark medical "DeepMeth Methylation Data Processing AI Model" stood out from nearly 10,000 studies and was included in the top international artificial intelligence conference AAAI'22
Time of Update: 2021-12-30
AI-based medical reference depth study (Deep Learning) of DeepMeth methylation data processing model is the world's first based on the depth study of methylated regions represented by a continuous vector of the algorithm , but also early detection of lung cancer medical reference product PulmoSeek TM Plus the core algorithm Foundation .
-
Yiqiao Shenzhou launches new coronavirus variant Omi Keron research reagent group
Time of Update: 2021-12-30
Yiqiao Shenzhou’s Omi Keron new product line includes recombinant Omi Keron spike proteins ( RBD , S1 and S-ECD trimers ), monoclonal antibodies that recognize Omi Keron spike proteins , and Omi Keron fake virus detection CRO service .
-
The first China Traditional Chinese Medicine Health (Macau) Brand Exhibition opened on December 10
Time of Update: 2021-12-30
Zhou Hui, chairman of the China Chamber of Commerce for Import and Export of Medicines and Health Products, believes that “this policy can promote the cooperation research on the quality standards of traditional Chinese medicines in the Guangdong-Hong Kong-Macao Greater Bay Area.
-
2021 Life Science Top Ten Innovative Product Selection Officially Launched
Time of Update: 2021-12-30
The emergence and breakthroughs of technologies such as CRISPR, microscopic imaging, single-cell analysis, and spatial transcriptomics have enabled the field of life sciences to develop higher, faster, and stronger, and have also allowed scientists to better answer health and disease-related issues.
-
Thermo Fisher Scientific completed the acquisition of PPD, Inc.
Time of Update: 2021-12-30
Waltham, quality . December 8, 2021/PRNewswire/-Thermo Fisher Scientific Inc. (NYSE: TMO), the world's leading service science company, announced today that it has completed its leading clinical re
-
Kanghong Pharmaceutical won the top three in the 2021 China Corporate Social Responsibility Development Index for the pharmaceutical and biological manufacturing industry
Time of Update: 2021-12-30
prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.
As a national pharmaceutical company that has grown up during the reform and opening up, Kanghong has always regarded providing the society with high-quality, professional and innovative pharmaceutical products and knowledge, and fundamentally improving patients' personal fitness and social medical efficiency as the company's most essential responsibility .
-
For the first-line treatment of small cell lung cancer, the international multi-center phase III clinical study of Fuhong Hanlius' PD-1 inhibitor, Slulimumab, reached the primary endpoint of OS
Time of Update: 2021-12-30
HK) announced that the company’s self-developed innovative PD-1 inhibitor slulimumab combined with chemotherapy is in A randomized, double-blind, international multi-center phase III clinical study (NCT04063163) of a previously untreated extensive-stage small cell lung cancer ( ES-SCLC ) has achieved overall survival ( OS ) in the first interim analysis The end .
-
Innovent announced the results of a phase Ib clinical study of GLP-1R/GCGR dual agonist IBI362 in Chinese patients with type 2 diabetes at the International Diabetes Federation Conference (IDF 2021) in 2021
Time of Update: 2021-12-30
/* Style Definitions */ span. prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a. prnews_a { color:blue; } li. prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p. prnews
-
Boehringer Ingelheim appoints Liu Jingxian as head of animal health business in Greater China
Time of Update: 2021-12-30
Before joining Boehringer Ingelheim, Liu Jingxian worked in Johnson & Johnson Greater China and the United States for 18 years and held various positions, including general manager of China and vice president of global marketing for baby products .
-
Beihai Kangcheng, a leading company in the treatment of rare diseases in China, successfully listed on the main board of Hong Kong
Time of Update: 2021-12-29
62em; font-family:"Arial"; color:black; margin:0in; } </>Shanghai, December 10, 2021/PRNewswire/ - On December 10, Beijing time, Qiming Venture Capital and China's rare disease treatment leader Beihai Kangcheng successfully listed on the main board of the Hong Kong Stock Exchange .
-
Beihai Kangcheng listed on the main board of the Hong Kong Stock Exchange
Time of Update: 2021-12-29
HK) is a company based in China Biopharmaceutical company, as a global leader in the field of rare diseases, Beihai Kangcheng is committed to the research, development and commercialization of innovative therapies .
-
WuXi AppTec received Frost & Sullivan "2021 Global Customer Value Leadership Award"
Time of Update: 2021-12-29
Frost & Sullivan believes that WuXi AppTec has been continuously accelerating pharmaceutical innovation through cost-effective and efficient "end-to-end" new drug research and development services, and continues to create value for customers , thus winning another honor .
-
Nobel Prize winners look to the future at Nobel Vision
Time of Update: 2021-12-29
62em; font-family:"Arial"; color:black; margin:0in; } </>Moscow, December 9, 2021/PRNewswire/ - Nobel Prize, Wolf Prize, Abel Prize and Fields Medal Winners, Leading Russian and Foreign Scientists, Futurists, "The World's Most Influential Participants, competent authorities and representatives of innovative companies selected on the Thinkers50 list have kept their vision for the future of technology in a “time capsule” .
-
400 million anti-epileptic drugs!
Time of Update: 2021-12-28
TOP5 generic names of terminal antiepileptic drugs in physical pharmacies in Chinese cities in 2020 Source: Mi Nei. com, China's urban physical pharmacy terminal competition pattern Among the TOP5 generic names of terminal antiepileptic drugs in physical pharmacies in Chinese cities, the top four products have sales of more than 100 million yuan, and lamotrigine ranks fourth .
